Results 211 to 220 of about 58,392 (301)

Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapy. [PDF]

Med Phys
Terro A, Perret S, Dumouchel A, Tonnelet D, Edet-Sanson A, Vera P, Decazes P, Dieudonné A.   +7 more
europepmc   +1 more source

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]

Front Nucl Med
Haugh KN, Sanwick AM, Chaple IF.
europepmc   +1 more source

Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis. [PDF]

ACS Cent Sci
Guo Z, Wang X, Han Y, Shen S, Tian P, Hu Y, Ding Z, Fu Q, Liu Z.   +8 more
europepmc   +1 more source

“How Do You Feel About Dosimetry?” The Gretchenfrage of Radionuclide Therapy [PDF]

Matthias Blaickner
openalex   +1 more source

Drug-Induced Liver Injury Secondary to Radionuclide Therapy With Lutetium-177 Vipivotide Tetraxetan in a Patient With Metastatic Castrate-Resistant Prostate Cancer. [PDF]

ACG Case Rep J
Lee BT, Kankotia RJ, Braxton D.
europepmc   +1 more source

Supplementary Figure S.4 from Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers

Maxim Kuznetsov, Vikram Adhikarla, Enrico Caserta, Xiuli Wang, John E. Shively, Flavia Pichiorri, Russell C. Rockne   +6 more
openalex   +1 more source

Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors. [PDF]

J Neuroendocrinol
Santo G, di Santo G, Cicone F, Virgolini I.   +3 more
europepmc   +1 more source

SSTR-directed peptide receptor radionuclide therapy for recurrent meningiomas: analysis of safety, efficacy and prognostic factors. [PDF]

Eur J Nucl Med Mol Imaging
Hasenauer N, Müller M, Hänscheid H, Serfling SE, Michalski K, Heinrich M, Polat B, Buck AK, Werner RA, Hartrampf PE.   +9 more
europepmc   +1 more source

²¹¹At on gold nanoparticles for targeted radionuclide therapy application

Jeffrey Tanudji, Hideaki Kasai, Michio Okada, Tetsuo Ogawa, Susan Meñez Aspera, Hiroshi Nakanishi   +5 more
openalex   +2 more sources

Current status and perspective of targeted radionuclide therapy for cancer

, 2014
Seigo Kinuya
openalex   +2 more sources